89 related articles for article (PubMed ID: 9935148)
1. Frequent aberration of the transforming growth factor-beta receptor II gene in cell lines but no apparent mutation in pre-invasive and invasive carcinomas of the uterine cervix.
Chu TY; Lai JS; Shen CY; Liu HS; Chao CF
Int J Cancer; 1999 Feb; 80(4):506-10. PubMed ID: 9935148
[TBL] [Abstract][Full Text] [Related]
2. Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta.
Kang SH; Won K; Chung HW; Jong HS; Song YS; Kim SJ; Bang YJ; Kim NK
Int J Cancer; 1998 Aug; 77(4):620-5. PubMed ID: 9679767
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
4. Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions.
Tani M; Takenoshita S; Kohno T; Hagiwara K; Nagamachi Y; Harris CC; Yokota J
Carcinogenesis; 1997 May; 18(5):1119-21. PubMed ID: 9163705
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability.
Akiyama Y; Iwanaga R; Ishikawa T; Sakamoto K; Nishi N; Nihei Z; Iwama T; Saitoh K; Yuasa Y
Cancer; 1996 Dec; 78(12):2478-84. PubMed ID: 8952554
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
7. Mutation of the transforming growth factor-beta type II receptor gene is a rare event in human sporadic gastric carcinomas.
Shitara Y; Yokozaki H; Yasui W; Takenoshita S; Nagamachi Y; Tahara E
Int J Oncol; 1998 May; 12(5):1061-5. PubMed ID: 9538129
[TBL] [Abstract][Full Text] [Related]
8. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
Carethers JM; Pham TT
In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
[TBL] [Abstract][Full Text] [Related]
9. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
[TBL] [Abstract][Full Text] [Related]
10. Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic human gastrointestinal cancer.
Tomita S; Miyazato H; Tamai O; Muto Y; Toda T
Cancer Genet Cytogenet; 1999 Nov; 115(1):23-7. PubMed ID: 10565295
[TBL] [Abstract][Full Text] [Related]
11. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
[TBL] [Abstract][Full Text] [Related]
12. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.
Myeroff LL; Parsons R; Kim SJ; Hedrick L; Cho KR; Orth K; Mathis M; Kinzler KW; Lutterbaugh J; Park K
Cancer Res; 1995 Dec; 55(23):5545-7. PubMed ID: 7585631
[TBL] [Abstract][Full Text] [Related]
13. Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers.
Knobloch TJ; Lynch MA; Song H; DeGroff VL; Casto BC; Adams EM; Alam KY; Lang JC; Schuller DE; Weghorst CM
Mutat Res; 2001 Aug; 479(1-2):131-9. PubMed ID: 11470488
[TBL] [Abstract][Full Text] [Related]
14. Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations.
Iacopetta BJ; Welch J; Soong R; House AK; Zhou XP; Hamelin R
J Pathol; 1998 Apr; 184(4):390-5. PubMed ID: 9664904
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas.
Izumoto S; Arita N; Ohnishi T; Hiraga S; Taki T; Tomita N; Ohue M; Hayakawa T
Cancer Lett; 1997 Jan; 112(2):251-6. PubMed ID: 9066736
[TBL] [Abstract][Full Text] [Related]
16. [Damage to the transforming growth factor TGF-beta type II receptor gene and microsatellite instability in carcinoma cells of the gastrointestinal tract].
Vostriukhina OA; Nikiforova IF; Shtam TA; Kantorov SL; Kovalev VK; Vasil'ev SV; Pozharisskiī KM; Lantsov VA
Vopr Onkol; 1998; 44(6):667-71. PubMed ID: 10087960
[TBL] [Abstract][Full Text] [Related]
17. A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability.
Togo G; Toda N; Kanai F; Kato N; Shiratori Y; Kishi K; Imazeki F; Makuuchi M; Omata M
Cancer Res; 1996 Dec; 56(24):5620-3. PubMed ID: 8971166
[TBL] [Abstract][Full Text] [Related]
18. Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck.
Wang D; Song H; Evans JA; Lang JC; Schuller DE; Weghorst CM
Carcinogenesis; 1997 Nov; 18(11):2285-90. PubMed ID: 9395234
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.
Franchi A; Gallo O; Sardi I; Santucci M
J Clin Pathol; 2001 Mar; 54(3):201-4. PubMed ID: 11253131
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
Hougaard S; Nørgaard P; Abrahamsen N; Moses HL; Spang-Thomsen M; Skovgaard Poulsen H
Br J Cancer; 1999 Mar; 79(7-8):1005-11. PubMed ID: 10098728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
